Cytonet is right on track Weinheim/Germany, February 2012 – „We’re making huge advances towards our goal - getting regulatory approval of liver cell therapy for children with the serious hereditary disease urea ... read on
Launch of a clinical trial on urea cycle activity Heidelberg/Germany, January 2012 – After being granted approval by the German Federal Institute of Drugs and Medical Devices (BfArM), a clinical trial on the diagnostics of urea cycle defects is ... read on
American SELICA III trial to be extended into Canada Weinheim/Germany, October 2011 – On September 14th, 2011 the Canadian health authority Health Canada granted Cytonet approval to extend the SELICA III trial, which has been running ... read on
